Search research articles
Contact Us
Filters
Showing results (101-110 of 186) with videos related to
Page
of 19
Sort By:
Revue Medicale De Liege
|
November 26, 2004
[Spondylocostal dysostosis: a rare genetic disease]
O Beine, J Bolland, A Verloes, et al.
BMJ (Clinical Research Ed.)
|
April 21, 2011
Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis
Mark J Bolland, Andrew Grey, Alison Avenell, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
March 26, 2004
Bilateral femoral head osteonecrosis after septic shock and multiorgan failure
Mark J Bolland, Gill Hood, Sonja T Bastin, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
September 13, 2017
Duration of antiresorptive activity of zoledronate in postmenopausal women with osteopenia: a randomized, controlled multidose trial
Andrew Grey, Mark J Bolland, Anne Horne, et al.
Annals of Clinical Biochemistry
|
January 25, 2025
Biochemical osteomalacia in adults undergoing vitamin D testing in the North-East of Scotland
Angus D Macleod, Mark J Bolland, Andrew Balfour, et al.
Bonekey Reports
|
August 17, 2013
Subgroup analysis for the risk of cardiovascular disease with calcium supplements
Loretta T Radford, Mark J Bolland, Greg D Gamble, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 4, 2008
The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal women
Andrew Grey, Mark J Bolland, Diana Wattie, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
December 16, 2014
Mendelian randomization analysis to examine for a causal effect of urate on bone mineral density
Nicola Dalbeth, Ruth Topless, Tanya Flynn, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 29, 2021
Bone Mineral Density and Bone Turnover 10 Years After a Single 5 mg Dose or Two 5-Yearly Lower Doses of Zoledronate in Osteopenic Older Women: An Open-Label Extension of a Randomized Controlled Trial
Andrew Grey, Mark J Bolland, Anne Horne, et al.
Annals of Clinical Biochemistry
|
May 18, 2006
A case of low cortisol-binding globulin: use of plasma free cortisol in interpretation of hypothalamic-pituitary-adrenal axis tests
James S Davidson, Mark J Bolland, Michael S Croxson, et al.
Page
of 19
Search research articles
Search
Showing results (101-110 of 186) with videos related to
Sort By:
Page
of 19
Revue Medicale De Liege
|
November 26, 2004
[Spondylocostal dysostosis: a rare genetic disease]
O Beine, J Bolland, A Verloes, et al.
BMJ (Clinical Research Ed.)
|
April 21, 2011
Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis
Mark J Bolland, Andrew Grey, Alison Avenell, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
March 26, 2004
Bilateral femoral head osteonecrosis after septic shock and multiorgan failure
Mark J Bolland, Gill Hood, Sonja T Bastin, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
September 13, 2017
Duration of antiresorptive activity of zoledronate in postmenopausal women with osteopenia: a randomized, controlled multidose trial
Andrew Grey, Mark J Bolland, Anne Horne, et al.
Annals of Clinical Biochemistry
|
January 25, 2025
Biochemical osteomalacia in adults undergoing vitamin D testing in the North-East of Scotland
Angus D Macleod, Mark J Bolland, Andrew Balfour, et al.
Bonekey Reports
|
August 17, 2013
Subgroup analysis for the risk of cardiovascular disease with calcium supplements
Loretta T Radford, Mark J Bolland, Greg D Gamble, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 4, 2008
The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal women
Andrew Grey, Mark J Bolland, Diana Wattie, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
December 16, 2014
Mendelian randomization analysis to examine for a causal effect of urate on bone mineral density
Nicola Dalbeth, Ruth Topless, Tanya Flynn, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
September 29, 2021
Bone Mineral Density and Bone Turnover 10 Years After a Single 5 mg Dose or Two 5-Yearly Lower Doses of Zoledronate in Osteopenic Older Women: An Open-Label Extension of a Randomized Controlled Trial
Andrew Grey, Mark J Bolland, Anne Horne, et al.
Annals of Clinical Biochemistry
|
May 18, 2006
A case of low cortisol-binding globulin: use of plasma free cortisol in interpretation of hypothalamic-pituitary-adrenal axis tests
James S Davidson, Mark J Bolland, Michael S Croxson, et al.
Page
of 19